{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:46:29Z","timestamp":1782319589726,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T00:00:00Z","timestamp":1360195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s10096-013-1822-z","type":"journal-article","created":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T15:55:28Z","timestamp":1360166128000},"page":"883-889","source":"Crossref","is-referenced-by-count":17,"title":["Central venous catheter-related blood stream infections in patients receiving intravenous iloprost for pulmonary hypertension"],"prefix":"10.1007","volume":"32","author":[{"given":"D.","family":"Sammut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"Elliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. G.","family":"Kiely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. J.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sephton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hurdman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Sabroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Condliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,7]]},"reference":[{"key":"1822_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","volume":"336","author":"LJ Rubin","year":"1997","unstructured":"Rubin LJ (1997) Primary pulmonary hypertension. N Engl J Med 336:111\u2013117","journal-title":"N Engl J Med"},{"key":"1822_CR2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","volume":"334","author":"RJ Barst","year":"1996","unstructured":"Barst RJ, Rubin LJ, Long WA et al (1996) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 334:296\u2013302","journal-title":"N Engl J Med"},{"key":"1822_CR3","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1164\/rccm.200505-766OC","volume":"172","author":"M Gomberg-Maitland","year":"2005","unstructured":"Gomberg-Maitland M, Tapson VF, Benza RL, McLaughlin VV, Krichman A, Widlitz AC, Barst RJ (2005) Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension. Am J Respir Crit Care Med 172:1586\u20131589","journal-title":"Am J Respir Crit Care Med"},{"key":"1822_CR4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/hrt.79.2.175","volume":"79","author":"TW Higenbottam","year":"1998","unstructured":"Higenbottam TW, Butt AY, Dinh-Xaun AT, Takao M, Cremona G, Akamine S (1998) Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost. Heart 79:175\u2013179","journal-title":"Heart"},{"key":"1822_CR5","doi-asserted-by":"crossref","unstructured":"Doran AK, Ivy DD, Barst RJ, Hill N, Murali S, Benza RL (2008) Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension. Int J Clin Pract Suppl 5\u20139","DOI":"10.1111\/j.1742-1241.2008.01811.x"},{"key":"1822_CR6","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s10096-003-1024-1","volume":"22","author":"RL Yap","year":"2003","unstructured":"Yap RL, Mermel LA (2003) Micrococcus infection in patients receiving epoprostenol by continuous infusion. Eur J Clin Microbiol Infect Dis 22:704\u2013705","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1822_CR7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1378\/chest.126.1.90","volume":"126","author":"RJ Oudiz","year":"2004","unstructured":"Oudiz RJ, Widlitz A, Beckmann XJ, Camanga D, Alfie J, Brundage BH, Barst RJ (2004) Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension. Chest 126:90\u201394","journal-title":"Chest"},{"key":"1822_CR8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1253\/circj.71.559","volume":"71","author":"S Akagi","year":"2007","unstructured":"Akagi S, Matsubara H, Ogawa A et al (2007) Prevention of catheter-related infections using a closed hub system in patients with pulmonary arterial hypertension. Circ J 71:559\u2013564","journal-title":"Circ J"},{"key":"1822_CR9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/529552","volume":"29","author":"AJ Kallen","year":"2008","unstructured":"Kallen AJ, Lederman E, Balaji A et al (2008) Bloodstream infections in patients given treatment with intravenous prostanoids. Infect Control Hosp Epidemiol 29:342\u2013349","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1822_CR10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1086\/605320","volume":"30","author":"DD Ivy","year":"2009","unstructured":"Ivy DD, Calderbank M, Wagner BD et al (2009) Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension. Infect Control Hosp Epidemiol 30:823\u2013829","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1822_CR11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1378\/chest.11-0245","volume":"141","author":"JD Rich","year":"2012","unstructured":"Rich JD, Glassner C, Wade M, Coslet S, Arneson C, Doran A, Gomberg-Maitland M (2012) The effect of diluent ph on bloodstream infection rates in patients receiving intravenous treprostinil for pulmonary arterial hypertension. Chest 141:36\u201342","journal-title":"Chest"},{"key":"1822_CR12","unstructured":"United Kingdom National Audit of Pulmonary Hypertension (2011) Pulmonary hypertension audit. http:\/\/www.ic.nhs.uk\/webfiles\/Services\/NCASP\/audits%20and%20reports\/NHS_IC_Pulmonary_Hypertension_Audit_V1.0.pdf . Accessed July 12, 2012"},{"key":"1822_CR13","unstructured":"Certificate of Analysis of Ilomedin, Bayer Healthcare on basis of HPLC assay performed by BerliMed, Madrid, Spain; March 2008"},{"key":"1822_CR14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1378\/chest.100.1.164","volume":"100","author":"RL Smith","year":"1991","unstructured":"Smith RL, Meixler SM, Simberkoff MS (1991) Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 100:164\u2013167","journal-title":"Chest"},{"key":"1822_CR15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2466-11-56","volume":"11","author":"L Knudsen","year":"2011","unstructured":"Knudsen L, Schurawlew A, Nickel N, Tiede H, Ghofrani HA, Wilkens H, Ewert R, Halank M, Klose H, Bazner C, Behr J, Hoeper MM (2011) Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy. BMC Pulm Med 11:56","journal-title":"BMC Pulm Med"},{"key":"1822_CR16","unstructured":"Centers for Disease Control and Prevention (CDC) (2007) Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension\u2014seven sites, United States, 2003\u20132006. MMWR Morb Mortal Wkly Rep 56:170\u2013172"},{"key":"1822_CR17","unstructured":"GlaxoSmithKline (2008) Flolan [package insert]. GlaxoSmithKline, Research Triangle Park, NC"},{"key":"1822_CR18","unstructured":"United Therapeutics Corporation (2008) Remodulin [package insert]. United Therapeutics Corporation, Research Triangle Park, NC"},{"key":"1822_CR19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1742-1241.2009.02307.x","volume":"64","author":"D Zaccardelli","year":"2010","unstructured":"Zaccardelli D, Phares K, Jeffs R, Doran A, Wade M (2010) Stability and antimicrobial effectiveness of treprostinil sodium in sterile diluent for Flolan. Int J Clin Pract 64:885\u2013891","journal-title":"Int J Clin Pract"},{"key":"1822_CR20","unstructured":"Amsha K, Armstrong IJ, Taylor EA, Lawson RA, Bates C, Kiely DG (2002) High incidence of bacteraemia complicating iv prostaglandin therapy in patients with pulmonary hypertension. In: European Respiratory Society Annual Congress, Abstract 2312, September 14\u201318 2002, Stockholm"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-013-1822-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-013-1822-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-013-1822-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:35:04Z","timestamp":1559122504000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-013-1822-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,7]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["1822"],"URL":"https:\/\/doi.org\/10.1007\/s10096-013-1822-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,7]]}}}